AMEX: INO       Inovio Pharma
Last Price Today's Change   Day's Range   Trading Volume
2.35   -0.09 (3.69%)  2.20 - 2.53  937,259


Avg Volume (4 weeks):794,190
4 Weeks Range:2.09 - 2.85
4 Weeks Price Volatility (%):
52 Weeks Range:1.915 - 5.47
52 Weeks Price Volatility (%):
Average Price Target: 0.70
Price Target Upside/Downside: -1.65


No recent Headlines for this stock.

Business Background

Inovio Pharmaceuticals, Inc. (Inovio) is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.

  Be the first to like this.
selamba so good counter
05/08/2013 8:11 PM


2804  2791  464  2911 

Top 10 Active Counters
 CHK 0.705+0.035 
 FCEL 0.827+0.282 
 AMD 37.435+0.725 
 AABA 19.630.00 
 ET 11.05-0.61 
 GE 11.246-0.174 
 DIS 145.93+7.35 
 BAC 32.69-0.40 
 I 15.425-4.965 
 UBER 26.495-0.205 
Partners & Brokers